This cluster is small but part of a larger 30-day insider selling trend of $402.3M (5.2% of market cap). Monitor for further insider sales or any negative catalysts that might explain the selling. The stock has strong analyst consensus (96% bullish) and prior reports show positive momentum, but heavy insider selling warrants caution.
SYRE drugs
SYRE drug pipeline →How the stock moved after the report
NEUTRAL VIEWSTOCK BELOW ENTRY AT T+60- T+0 · Jul 6 $86.63entry
- T+1 · 4mo ago +2.44%α +1.56% · $88.74
- T+5 · 4mo ago +13.99%α +13.06% · $98.75
- T+20 · 4mo ago +17.16%α +17.58% · $101.50
- T+60 · 7w ago −0.97%α −4.54% · $85.79
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
A small insider selling cluster at Spyre Therapeutics (SYRE) saw CEO Turtle Cameron and CFO Scott Burrows sell a combined $1.33M in open-market transactions over a 7-day window. While the cluster itself is negligible relative to the $7.8B market cap (0.017%), it is part of a much larger 30-day insider selling pattern totaling $402.3M (5.2% of market cap), which raises caution despite strong analyst consensus.
Key Financial Metrics
Key Facts
- CEO Turtle Cameron sold 15,000 shares across three trades on 2026-07-01 for ~$1.33M at prices $87.44-$88.91.
- CFO Scott Burrows sold 5,000 shares on 2026-06-25 at $87.12 for $436K.
- Total cluster value of $1.33M is 0.017% of SYRE's $7.8B market cap.
- Over the prior 30 days, SYRE insiders have sold a total of $402.3M across 6 transactions, representing 5.2% of market cap.
Financial Impact
Insider selling of $1.33M in this cluster is immaterial on its own, but the broader 30-day selling of $402.3M is highly material at 5.2% of market cap.
Risk Factors
- Continued insider selling may indicate lack of confidence in near-term prospects.
- Potential overhang from large insider sales could pressure the stock.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CLUSTER Data (Synthetic) | cluster-SYRE-1783042357668 |
Track record
36 reports on SYRE
8 of 12 bullish or bearish reports moved the stock their way by T+60. Best: +54.27% at T+60 after the Apr 13, 2026 report. 15 of 21 went positive at some point.
Filters
- Nov 3, 202613d ago 8-K Neutral 5/10 No price data
- Nov 3, 202613d ago Press Release Bearish 5/10 Entry $99.04 Now $99.37 −0.33% settles Feb 2
- Oct 12, 20265w ago Institutional Cluster Bullish 4/10 Entry $85.90 Now $99.37 +15.68% settles Jan 7
- Oct 9, 20265w ago SC 13D/A Neutral 3/10 Entry $85.90 Now $99.37 +15.68% settles Jan 7
- Oct 7, 20265w ago 8-K Bearish 5/10 Entry $80.85 Now $99.37 −22.91% settles Jan 4
- Oct 6, 20265w ago 424B5 Bearish 6/10 Entry $80.85 Now $99.37 −22.91% settles Jan 4
- Oct 5, 20266w ago Press Release Bearish 6/10 Entry $80.11 Now $99.37 −24.04% settles Dec 31
- Oct 5, 20266w ago 424B5 Bearish 5/10 Entry $80.11 Now $99.37 −24.04% settles Dec 31
- Oct 5, 20266w ago Press Release Bearish 5/10 Entry $80.11 Now $99.37 −24.04% settles Dec 31
- Oct 2, 20266w ago Insider Cluster Bearish 4/10 Entry $92.72 Now $99.37 −7.17% settles Dec 30
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers